(Q58619075)
Statements
Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods (English)
C Oakman
W M Claudino
S Cappadona
S Nepi
A Battaglia
P Bernini
E Zafarana
M Fornier
P G Morris